This educational activity introduces clinicians to advanced diagnostics and management strategies for ocular surface disease. Through case presentations and discussions, the program delves into the latest clinical data and treatment methodologies, including the use of targeted therapies for Demodex blepharitis. Participants will engage in a comprehensive review of ocular surface disease, from identifying key signs and symptoms to exploring effective treatment plans. The desired results of this educational activity are for clinicians to implement best practices in the diagnosis of patients with blepharitis, gain confidence in developing individualized treatment plans for patients with blepharitis, and review relevant clinical data on emerging treatments for blepharitis.
- Provider:MedEdicus, LLC
- Activity Link: https://courses.mededicus.com/content/current-and-emerging-treatments-management-ocular-surface-disease-targeting-mites-and-more-0#group-tabs-node-course-default1
- Start Date: 2024-01-10 06:00:00
- End Date: 2024-01-10 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Tarsus Pharmaceuticals, Inc - Amount: 17877.0 - Is Kind Support: False Source: Théa Pharma Inc - Amount: 17877.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Directly Provided
- Registration: Limited